Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene

Pharmaceutical Research

Volumn 24, Issue 9, 2007, Pages 1628-1635

  Nakamura, Toshimichi ^a   Sugiura, Shigeki ^b   Kobayashi, Daisuke ^a   Yoshida, Kenji ^a   Yabuuchi, Hikaru ^c   Aizawa, Shin ^d   Maeda, Tomoji ^a   Tamai, Ikumi ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c GenoMembrane Inc   (Japan)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Ergothioneine; Erythrocyte; K562; OCTN1; siRNA; Transporter

Indexed keywords

BUTYRIC ACID; OCTAMER TRANSCRIPTION FACTOR 1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; THIONEINE; TRITIUM;

ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CROHN DISEASE; ERYTHROID CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

CELL DIFFERENTIATION; CELL PROLIFERATION; ERGOTHIONEINE; ERYTHROID CELLS; HUMANS; K562 CELLS; ORGANIC CATION TRANSPORT PROTEINS; RNA, SMALL INTERFERING;

EID: 34547631471     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9290-8     Document Type: Article

References (27)

1. I. Tamai, H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, and A. Tsuji. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419:107-111 (1997).
2. H. Yabuuchi, I. Tamai, J. Nezu, K. Sakamoto, A. Oku, M. Shimane, Y. Sai, and A. Tsuji. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Exp. Ther. 289:768-773 (1999).
3. I. Tamai, R. Ohashi, J. Nezu, H. Yabuuchi, A. Oku, M. Shimane, Y. Sai, and A. Tsuji. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273:20378-20382 (1998).
4. I. Tamai, R. Ohashi, J. Nezu, Y. Sai, D. Kobayashi, A. Oku, M. Shimane, and A. Tsuji. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J. Biol. Chem. 275:40064-40072 (2000).
5. J. Nezu, I. Tamai, A. Oku, R. Ohashi, H. Yabuuchi, N. Hashimoto, H. Nikaido, Y. Sai, A. Koizumi, Y. Shoji, G. Takada, T. Matsuishi, M. Yoshino, H. Kato, T. Ohura, G. Tsujimoto, J. Hayakawa, M. Shimane, and A. Tsuji. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 21:91-94 (1999).
6. I. Tamai, T. Nakanishi, D. Kobayashi, K. China, Y. Kosugi, J. Nezu, Y. Sai, and A. Tsuji. Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol. Pharm. 1:57-66 (2004).
7. D. Kobayashi, S. Aizawa, T. Maeda, I. Tsuboi, H. Yabuuchi, J. Nezu, A. Tsuji, and I. Tamai. Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation. Exp. Hematol. 32:1156-1162 (2004).
8. S. Tokuhiro, R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, H. Furukawa, M. Nagashima, S. Yoshino, A. Mabuchi, A. Sekine, S. Saito, A. Takahashi, T. Tsunoda, Y. Nakamura, and M. Yamamoto. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341-348 (2003).
9. V. Peltekova, R. F. Wintle, L. A. Rubin, C. L. Amos, Q. Huang, X. Gu, B. Newman, M. V. Oene, D. Cescon, G. Greenberg, A. M. Griffiths, P. H. St George-Hyslop, and K. A. Siminovitch. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36:471-475 (2004).
10. K. Yamazaki, M. Takazae, T. Tanaka, T. Ichimori, S. Saito, A. Iida, Y. Onouchi, A. Hata, and Y. Nakamura. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J. Hum. Genet. 49:664-668 (2004).
11. D. Gründemann, S. Harlfinger, S. Golz, A. Geerts, A. Lazar, R. Berkels, N. Jung, A. Rubbert, and E. Schomig. Discovery of ergothioneine transporter. Proc. Natl. Sci. U.S.A. 102:5256-5261 (2005).
12. D. Taubert, G. Grimberg, N. Jung, A. Rubbert, and E. Schomig. Function role of the 503F variant of the organic cation transporter OCTN1 in Crohn's disease. Gut 54:1505-1506 (2005).
13. T. Mayumi, K. Okamoto, K. Yoshida, Y. Kawai, H. Kawano, T. Hama, and K. Tanaka. Studies on Ergothioneine. VIII. Preventive effects of ergothioneine on cadmium-induced teratogenesis. Chem. Pharm. Bull. 30:2141-2146 (1982).
14. P. E. Hartman. Ergothioneine as antioxidant. Methods Enzymol. 186:310-318 (1990).
15. Y. Shima, T. Maeda, S. Aizawa, I. Tsuboi, D. Kobayashi, R. Kato, and I. Tamai. L-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes. Blood 107:1352-1356 (2006).
16. C. P. Perkins, V. Mar, J. R. Shutter, J. del Castillo, D. M. Danilenko, E. S. Medlock, I. L. Ponting, M. Graham, K. L. Stark, Y. Zuo, J. M. Cunningham, and R. A. Bosselman. Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. Genes Dev. 11:914-925 (1997).
17. M. Jordan, A. Schalhorn, and F. M. Wurm. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24:596-601 (1996).
18. T. Nozawa, M. Nakajima, I. Tamai, K. Noda, J. Nezu, Y. Sai, A. Tsuji, and T. Yokoi. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele frequencies in the Japanese population and functional analysis. J. Pharmacol. Exp. Ther. 302:804-813 (2002).
19. C. Zhang, Z. Ao, A. Seth, and S. F. Schlossman. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J. Immunol. 157:3980-3987 (1996).
20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
21. K. Yamaoka, Y. Tanigawa, T. Nakagawa, and A. Uno. pharmacokinetic analysis programa (multi) for microcomputer. J. Pharmacobiodyn. 4:879-885 (1981).
22. Y. Kawasaki, Y. Kato, Y. Sai, and A. Tsuji. Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. J. Pharm. Sci. 93:2920-2926 (2004).
23. T. Konishi, N. Tamaki, F. Tunemori, N. Masumitu, H. Okumura, and T. Hama. Studies on ergothioneine (II) origin of ergothioneine in the animal organs. Vitamins 46:127-129 (1972).
24. J.-H. Jang, O. I. Aruoma, L. S. Jen, H. Y. Chung, and Y. J. Surh. Ergothioneine resucues PC12 cells from β-amyloid-induced apoptotic death. Free Radic. Biol. Med. 36:288-299 (2004).
25. T. Maeda, T. Wakasawa, Y. Shima, I. Tsuboi, S. Aizawa, and I. Tamai. Biol. Pharm. Bull. 29:234-239 (2006).
26. K. Oishi, S. Hofmann, G. A. Diaz, B. Tartania, D. Manwani, L. Ng, R. Young, H. Vlassara, Y. A. Loannou, D. Forrest, and B. D. Gelb. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum. Mol. Genet. 11:2951-2960 (2002).
27. T. Maeda, M. Hirayama, D. Kobayashi, K. Miyazawa, and I. Tamai. Mechanism of the regulation of OCTN1 transporter (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines. Drug Metab. Dispos. 35:394-401 (2007).